We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+6.03%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$11.2B
AUM Growth
-$925M
Cap. Flow
-$880M
Cap. Flow %
-7.89%
Top 10 Hldgs %
15.04%
Holding
603
New
165
Increased
118
Reduced
122
Closed
159

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$142M
2
SWKS icon
Skyworks Solutions
SWKS
+$123M
3
EQH icon
Equitable Holdings
EQH
+$118M
4
TGT icon
Target
TGT
+$110M
5
CSCO icon
Cisco
CSCO
+$103M

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$155M
2
NXPI icon
NXP Semiconductors
NXPI
+$138M
3
CRM icon
Salesforce
CRM
+$124M
4
AKAM icon
Akamai
AKAM
+$114M
5
PF
Pinnacle Foods, Inc.
PF
+$113M

Sector Composition

Rank Sector Weight
1 Technology 18.82%
2 Industrials 16.36%
3 Energy 11.6%
4 Financials 11.57%
5 Healthcare 11.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GNCA
376
DELISTED
Genocea Biosciences, Inc.
GNCA
$1.37M 0.01%
200,386
-28,965
-13% -$217K
SCPH
377
DELISTED
scPharmaceuticals
SCPH
$1.31M 0.01%
230,819
+7,381
+3% +$75.8K
SGYP
378
CALL
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$1.3M 0.01%
750,000
– –
KZR
379
DELISTED
Kezar Life Sciences
KZR
$1.3M 0.01%
+7,500
New +$1.31M
OC icon
380
Owens Corning
OC
$12.4B
$1.29M 0.01%
20,425
-54,721
-73% -$3.78M
AWI icon
381
Armstrong World Industries
AWI
$7.84B
$1.29M 0.01%
+20,466
New +$1.22M
GNCA
382
CALL
DELISTED
Genocea Biosciences, Inc.
GNCA
$1.28M 0.01%
187,500
– –
EA
383
DELISTED
Electronic Arts
EA
$1.26M 0.01%
+8,959
New +$1.16M
OMED
384
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$1.23M 0.01%
534,309
+17,086
+3% +$49.8K
BFH icon
385
Bread Financial
BFH
$4.38B
$1.2M 0.01%
+6,433
New +$1.1M
TOVX icon
386
CALL
Theriva Biologics
TOVX
$10.1M
$1.2M 0.01%
571
– –
HCSG icon
387
Healthcare Services Group
HCSG
$1.53B
$1.17M 0.01%
+26,972
New +$1.07M
UBX
388
DELISTED
Unity Biotechnology
UBX
$1.14M 0.01%
+7,588
New +$1.11M
ACEL icon
389
CALL
Accel Entertainment
ACEL
$987M
$1.13M 0.01%
666,667
– –
COR icon
390
Cencora
COR
$61.2B
$1.11M 0.01%
+13,044
New +$1.15M
ATXS
391
DELISTED
Astria Therapeutics
ATXS
$1.08M 0.01%
18,692
+16,732
+854% +$1.54M
RCUS icon
392
Arcus Biosciences
RCUS
$3.64B
$1.07M 0.01%
87,808
+2,808
+3% +$44.1K
AUPH icon
393
Aurinia Pharmaceuticals
AUPH
$2.11B
$1.06M 0.01%
188,709
-387,615
-67% -$2.16M
ADMS
394
DELISTED
Adamas Pharmaceuticals
ADMS
$1.03M 0.01%
39,827
+1,274
+3% +$35.3K
IDXX icon
395
Idexx Laboratories
IDXX
$46.2B
$1.03M 0.01%
+4,707
New +$970K
AMR
396
CALL
DELISTED
Alta Mesa Resources Inc
AMR
$989K 0.01%
145,208
+2,991
+2% +$21.6K
ORGO icon
397
CALL
Organogenesis Holdings
ORGO
$239M
$987K 0.01%
2,100,000
– –
HTGM
398
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$978K 0.01%
+1,667
New +$1.09M
AKBA icon
399
Akebia Therapeutics
AKBA
$252M
$975K 0.01%
97,734
-4,701
-5% -$47.1K
EVFM
400
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$963K 0.01%
+23,695
New +$1.86M
14 15
16
17 18

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q2 2018 Portfolio in Review

As of Q2 2018, Alyeska Investment Group held 603 positions worth $11.2B, down 7.7% from $12.1B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Alyeska Investment Group withdrew a net $880M in Q2 2018, closing 159 positions and reducing 122 holdings. Its most notable exit was IBM, an estimated $155M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Industrials and Energy.

Against the trend, Alyeska Investment Group opened a new position in Skyworks Solutions worth $122M.

  • Alyeska Investment Group's largest Q2 2018 buy was Skyworks Solutions: 1,261,692 shares worth $122M.
  • Alyeska Investment Group added most to Alphabet (Google) Class A in Q2 2018, an estimated $142M increase.
  • Alyeska Investment Group's biggest Q2 2018 reduction was Salesforce, cutting an estimated $124M.
  • Alyeska Investment Group fully exited IBM in Q2 2018, selling an estimated $155M.
  • Alyeska Investment Group's ten largest holdings make up 15% of its $11.2B portfolio in Q2 2018.
  • Alyeska Investment Group opened 165 new positions and closed 159 in Q2 2018.
  • Alyeska Investment Group's portfolio value fell 7.7% quarter-over-quarter to $11.2B.

Based on Alyeska Investment Group's 13F filing for Q2 2018, filed 14 Aug 2018.